|
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.Medical review was performed: this was a case to treat a perforation in a mid-left anterior descending artery (mid-lad) in a 63-year-old male patient who presented with an st elevated myocardial infarction (stemi).It was reported that the perforation occurred after an atherectomy in the mid-lad.Due to the information provided, it can not be definitively stated that the 2.8 x 16 graftmaster was the direct contributor or cause of this patient¿s death.It is unknown why the 2.8 x 16 failed to reach the lesion.The patient was experiencing an st elevated myocardial infarction (stemi) at the time of the procedure.The morphology of their coronary arteries is unknown, as is the vessel dominance.The implantation of the 3.5 x 16 graftmaster in the lm and lcx, effectively jailing off the lad artery entirely, is most likely a direct cause of this patient¿s death.However, it is not clear if this is due to a product failure, the patient¿s medical status, or, rather, a medical procedural decision in an attempt to seal the mid-lad perforation.If additional information is received, this medical review will be updated as required.Based on the information provided, a definitive cause for the reported issue could not be determined.Based on the results of the complaint investigation, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|